Valuation: Renata PLC

Market Cap 51.76B 421M 368M 340M 317M 597M 39.77B 608M 4.08B 1.58B 19.63B 1.58B 1.55B 68.38B P/E 2026 *
18.6x
P/E 2027 * 12.6x
Enterprise Value 51.76B 421M 368M 340M 317M 597M 39.77B 608M 4.08B 1.58B 19.63B 1.58B 1.55B 68.38B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.94x
Free-Float
17.05%
Yield 2026 *
1.25%
Yield 2027 * 3.2%
1 day+1.04%
1 week+1.97%
Current month+10.14%
1 month+10.14%
3 months+6.24%
6 months+16.50%
Current year+16.39%
1 week 443.7
Extreme 443.7
457
1 month 412.6
Extreme 412.6
459.7
Current year 381.8
Extreme 381.8
488
1 year 372
Extreme 372
548
3 years 372
Extreme 372
1,217.9
5 years 372
Extreme 372
1,289.72
10 years 372
Extreme 372
1,289.72
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2001-12-31
Chairman 84 -
Director/Board Member - 2013-08-26
Change 5-day change 1-year change 3-year change Capi.($)
+1.04%+1.97%-7.01%-62.56% 421M
-2.48%+8.34%+53.87%+155.75% 1,097B
-1.76%+6.23%+66.27%+53.44% 622B
-1.05%+7.19%+35.57%+86.77% 449B
-1.62%+6.34%+29.51%+24.01% 334B
-1.38%+6.09%+37.91%+25.49% 294B
+0.30%+5.24%+31.61%+42.02% 286B
-0.10%+4.88%-28.09%-41.02% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.52%+6.35%+26.33%+41.09% 364.72B
Weighted average by Cap. -1.12%+8.72%+40.66%+77.90%

Financials

2026 *2027 *
Net sales 47.45B 386M 338M 312M 291M 548M 36.46B 557M 3.74B 1.45B 17.99B 1.45B 1.42B 62.68B 55.08B 448M 392M 362M 337M 636M 42.33B 647M 4.34B 1.68B 20.89B 1.68B 1.64B 72.76B
Net income 2.81B 22.85M 20M 18.46M 17.22M 32.45M 2.16B 33.03M 221M 85.97M 1.07B 85.84M 83.92M 3.71B 4.39B 35.66M 31.21M 28.81M 26.87M 50.64M 3.37B 51.54M 346M 134M 1.66B 134M 131M 5.8B
Net Debt - -
Logo Renata PLC
Renata PLC is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing, marketing and distribution of pharmaceuticals, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. It operates in several modalities, such as oral solids dosage forms, which include tablets, capsules, OROS, oral dispersible tablets; soft gels injectables, which include hormone injectables, general injectables and oncology injectables; inhalers, which include DPI and MDI, and nutraceutical products. Its offering includes anthelmintic, live vaccines, nutrition products, vitamins & minerals, anti-gout, anti-spasmodic, and anti-allergic. The Company has approximately 14 manufacturing facilities spread over three manufacturing sites.
Employees
8,366
Date Price Change Volume
26-06-29 BDT 456.00 +1.04% 70,910
26-06-29 BDT 451.30 0.00% 93,370
26-06-28 BDT 451.30 +1.12% 95,151
26-06-25 BDT 446.30 +0.27% 47,107
26-06-24 BDT 445.10 0.00% 61,701
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
456.00BDT
Average target price
615.05BDT
Spread / Average Target
+34.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENATA Stock